QIZHI YAO to HIV Infections
This is a "connection" page, showing publications QIZHI YAO has written about HIV Infections.
Connection Strength
0.865
-
The Human Immune Response to HIV and its Impact in the Potential Development of an Inactivated HIV Vaccine. AIDS Rev. 2016 Jul-Sep; 18(3):151-157.
Score: 0.230
-
HIV inactivation: time for a second look. AIDS. 2015 Jan 02; 29(1):129-31.
Score: 0.208
-
Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV. Vaccine. 2010 Jul 12; 28(31):5114-27.
Score: 0.151
-
Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV. Vaccine. 2016 11 21; 34(48):5886-5894.
Score: 0.059
-
Complete and repeatable inactivation of HIV-1 viral particles in suspension using a photo-labeled non-nucleoside reverse transcriptase inhibitor. J Virol Methods. 2013 Apr; 189(1):125-8.
Score: 0.045
-
Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug; 18(8):BR293-298.
Score: 0.044
-
Nordihydroguaiaretic acid (NDGA) inhibits ritonavir-induced endothelial dysfunction in porcine pulmonary arteries. Med Sci Monit. 2011 Nov; 17(11):BR312-318.
Score: 0.042
-
Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg. 2007 Apr; 31(4):632-43.
Score: 0.030
-
Abdominal aortic surgery in patients with human immunodeficiency virus infection. Am J Surg. 2004 Dec; 188(6):690-7.
Score: 0.026
-
Acute limb ischemia secondary to myositis-induced compartment syndrome in a patient with human immunodeficiency virus infection. J Vasc Surg. 2003 May; 37(5):1103-5.
Score: 0.023
-
Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr. 2007 Apr 15; 44(5):493-9.
Score: 0.008